US Revives Drug Origin Debate, Cites Indian Exports

2026-01-30 - 09:25

US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions